The 2026 Biopharma Pipeline: Breakthrough Drugs Reshaping the Industry
May 1, 2026
No Comments
“After several years of headwinds, the backdrop for pharma and biotech has turned more constructive, supported by improved policy visibility, renewed M&A activity, and strong market performance.” — Janus Henderson, March 2026 2026 is shaping up